NEW YORK (AP) — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and Nasdaq Stock Market:
Eli Lilly & Co., down $1.60 at $49
The drugmaker is planning another study for a potential Alzheimer's treatment, delaying possible FDA approval and the drug's sale.
Aetna Inc., up $1.43 at $45.91
A Goldman Sachs analyst says the health insurer's initial forecast for 2013 may have been stronger than some investors expected.
Teva Pharmaceutical Industries Ltd., down $2.20 at $39.47
Some analysts are disappointed that the drugmaker didn't give more specific details about the drugs it's working on.
YM BioSciences Inc., up $1.25 at $2.88
The Canadian drug developer is being bought by Gilead Sciences for $2.95 per share, an 81 percent premium.
For the more heavily traded Class B shares of Berkshire Hathaway Inc., up $2.05 at $89.32
Warren Buffett's company is paying $1.2 billion to buy back 9,200 Class A shares, and the board approves higher prices for future buybacks.
Coinstar Inc., up $1.15 at $51.96
The company's DVD kiosk operator, Redbox, is starting an unlimited streaming-video plan for $8 a month in a challenge to Netflix.
Charles River Laboratories International Inc., down $3.65 at $35.65
The medical research equipment provider's profit prediction for 2013 falls short of the average estimate of Wall Street analysts.
Ziopharm Oncology Inc., down 27 cents at $4.17
A Jefferies analyst thinks the drug developer's experimental cancer drug may not be effective enough to win regulatory approval.
Here are 15 of Eric Boehlert's comically wrong tweets about Iowa
Tonight's New Hampshire GOP Debate Preview | RedState
America is a Nation Headed For a Fall
Supreme Court likely to hear new “assault weapons” ban case
Concealed Carrier Thwarts Possible Mass Shooting in NOLA
Mike Shedlock - World's First Robot-Run Lettuce Farm to Produce 30,000 Heads Daily; Tipping Point for Workerless Agriculture
Why Muslim Rapists Prefer Blondes: A History | Human Events